Research
Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise
Holger J. Schünemann, Wojtek Wiercioch, Itziar Etxeandia, Maicon Falavigna, Nancy Santesso, Reem Mustafa, Matthew Ventresca, Romina Brignardello-Petersen, Kaja-Triin Laisaar, Sérgio Kowalski, Tejan Baldeh, Yuan Zhang, Ulla Raid, Ignacio Neumann, Susan L. Norris, Judith Thornton, Robin Harbour, Shaun Treweek, Gordon Guyatt, Pablo Alonso-Coello, Marge Reinap, Jan Brožek, Andrew Oxman and Elie A. Akl
CMAJ February 18, 2014 186 (3) E123-E142; DOI: https://doi.org/10.1503/cmaj.131237
Holger J. Schünemann
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Wojtek Wiercioch
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Itziar Etxeandia
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Maicon Falavigna
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Nancy Santesso
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Reem Mustafa
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Matthew Ventresca
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Romina Brignardello-Petersen
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Kaja-Triin Laisaar
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Sérgio Kowalski
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Tejan Baldeh
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Yuan Zhang
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Ulla Raid
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Ignacio Neumann
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Susan L. Norris
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Judith Thornton
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Robin Harbour
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Shaun Treweek
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Gordon Guyatt
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Pablo Alonso-Coello
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Marge Reinap
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Jan Brožek
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Andrew Oxman
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Elie A. Akl
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Abstract
Background: Although several tools to evaluate the credibility of health care guidelines exist, guidance on practical steps for developing guidelines is lacking. We systematically compiled a comprehensive checklist of items linked to relevant resources and tools that guideline developers could consider, without the expectation that every guideline would address each item.
Methods: We searched data sources, including manuals of international guideline developers, literature on guidelines for guidelines (with a focus on methodology reports from international and national agencies, and professional societies) and recent articles providing systematic guidance. We reviewed these sources in duplicate, extracted items for the checklist using a sensitive approach and developed overarching topics relevant to guidelines. In an iterative process, we reviewed items for duplication and omissions and involved experts in guideline development for revisions and suggestions for items to be added.
Results: We developed a checklist with 18 topics and 146 items and a webpage to facilitate its use by guideline developers. The topics and included items cover all stages of the guideline enterprise, from the planning and formulation of guidelines, to their implementation and evaluation. The final checklist includes links to training materials as well as resources with suggested methodology for applying the items.
Interpretation: The checklist will serve as a resource for guideline developers. Consideration of items on the checklist will support the development, implementation and evaluation of guidelines. We will use crowdsourcing to revise the checklist and keep it up to date.
In this issue
Article tools
Respond to this article
Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise
Holger J. Schünemann, Wojtek Wiercioch, Itziar Etxeandia, Maicon Falavigna, Nancy Santesso, Reem Mustafa, Matthew Ventresca, Romina Brignardello-Petersen, Kaja-Triin Laisaar, Sérgio Kowalski, Tejan Baldeh, Yuan Zhang, Ulla Raid, Ignacio Neumann, Susan L. Norris, Judith Thornton, Robin Harbour, Shaun Treweek, Gordon Guyatt, Pablo Alonso-Coello, Marge Reinap, Jan Brožek, Andrew Oxman, Elie A. Akl
CMAJ Feb 2014, 186 (3) E123-E142; DOI: 10.1503/cmaj.131237
Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise
Holger J. Schünemann, Wojtek Wiercioch, Itziar Etxeandia, Maicon Falavigna, Nancy Santesso, Reem Mustafa, Matthew Ventresca, Romina Brignardello-Petersen, Kaja-Triin Laisaar, Sérgio Kowalski, Tejan Baldeh, Yuan Zhang, Ulla Raid, Ignacio Neumann, Susan L. Norris, Judith Thornton, Robin Harbour, Shaun Treweek, Gordon Guyatt, Pablo Alonso-Coello, Marge Reinap, Jan Brožek, Andrew Oxman, Elie A. Akl
CMAJ Feb 2014, 186 (3) E123-E142; DOI: 10.1503/cmaj.131237
Jump to section
Related Articles
Cited By...
- Methods used to select results to include in meta-analyses of nutrition research: a meta-research study
- Clinical practice guideline adaptation methods in resource-constrained settings: four case studies from South Africa
- Recommandations canadiennes pour les pratiques optimales de prise en charge de la sclerose laterale amyotrophique
- Canadian best practice recommendations for the management of amyotrophic lateral sclerosis
- Going "the Last Mile" With Guidelines for Deferred Umbilical Cord Clamping
- Financial conflict of interest among clinical practice guideline-producing organisations
- Assessing the process and outcome of the development of practice guidelines and recommendations: PANELVIEW instrument development
- Diagnosing acute aortic syndrome: a Canadian clinical practice guideline
- 'Building on shaky ground--challenges to and solutions for primary care guideline implementation in four provinces in South Africa: a qualitative study
- Management of the neurologically deceased organ donor: A Canadian clinical practice guideline
- Extending the RIGHT statement for reporting adapted practice guidelines in healthcare: the RIGHT-Ad@pt Checklist protocol
- Reporting, presentation and wording of recommendations in clinical practice guideline for gout: a systematic analysis
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism
- American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism
- Strengthening the quality of paediatric primary care: protocol for the process evaluation of a health systems intervention in South Africa
- PACK Child: the development of a practical guide to extend the scope of integrated primary care for children and young adolescents
- A systematic review of how patients value COPD outcomes
- Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline
- Deprescription des agonistes des recepteurs des benzodiazepines: Lignes directrices de pratique clinique fondees sur les donnees probantes
- Choosing guidelines to use in your practice
- Choisir les guides de pratique clinique a utiliser
- Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline
- Deprescription des antipsychotiques pour les symptomes comportementaux et psychologiques de la demence et linsomnie: Guide de pratique clinique fonde sur des donnees probantes
- Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline
- Deprescription des antihyperglycemiants chez les personnes agees: Guide de pratique clinique fonde sur les donnees probantes
- Perspective: Improving Nutritional Guidelines for Sustainable Health Policies: Current Status and Perspectives
- Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline
- Deprescrire les inhibiteurs de la pompe a protons: Lignes directrices de pratique clinique fondees sur les donnees probantes
- World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
- The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines
- Do "Evidence-Based Recommendations" Need to Reveal the Evidence? Minimal Criteria Supporting an "Evidence Claim"
- The development of guideline implementation tools: a qualitative study
- Do guidelines offer implementation advice to target users? A systematic review of guideline applicability
More in this TOC Section
Similar Articles
Collections
